BACKGROUND: Soluble tumor necrosis factor receptor (sTNFr) and interleukin-1 receptor antagonist (IL-1ra) have been identified as endogenous inhibitors of TNF-alpha and IL-1beta. While TNF-alpha and IL-1beta levels are not systematically elevated in postinjury patients who developed multiorgan failure (MOF), their involvement at the tissue level has been suggested. Our study hypothesis was that levels of sTNFr-I and IL-1ra would discriminate patients at risk for postinjury MOF. METHODS: Serial plasma levels of sTNFr and IL-1ra were measured in 29 trauma patients at high risk for postinjury MOF. RESULTS: sTNFr-I levels were higher in MOF compared with non-MOF patients at 12, 84, and 132 hours postinjury. MOF patients also had higher IL-1ra values 36, 60, 84, and 132 hours postinjury. CONCLUSIONS: Anti-inflammatory mechanisms are activated after trauma. Since increased levels of sTNFr and IL-1ra correlate with postinjury MOF, they may contribute to our understanding of the pathogenesis as well as prediction of outcome. High levels of antagonists to TNF-alpha and IL-1beta suggest tissue level involvement of these cytokines in postinjury hyperinflammation.
BACKGROUND: Soluble tumornecrosis factor receptor (sTNFr) and interleukin-1 receptor antagonist (IL-1ra) have been identified as endogenous inhibitors of TNF-alpha and IL-1beta. While TNF-alpha and IL-1beta levels are not systematically elevated in postinjury patients who developed multiorgan failure (MOF), their involvement at the tissue level has been suggested. Our study hypothesis was that levels of sTNFr-I and IL-1ra would discriminate patients at risk for postinjury MOF. METHODS: Serial plasma levels of sTNFr and IL-1ra were measured in 29 traumapatients at high risk for postinjury MOF. RESULTS: sTNFr-I levels were higher in MOF compared with non-MOF patients at 12, 84, and 132 hours postinjury. MOF patients also had higher IL-1ra values 36, 60, 84, and 132 hours postinjury. CONCLUSIONS: Anti-inflammatory mechanisms are activated after trauma. Since increased levels of sTNFr and IL-1ra correlate with postinjury MOF, they may contribute to our understanding of the pathogenesis as well as prediction of outcome. High levels of antagonists to TNF-alpha and IL-1beta suggest tissue level involvement of these cytokines in postinjury hyperinflammation.
Authors: Robert Slotwiński; Waldemar L Olszewski; Andrzej Chaber; Maciej Slodkowski; Marzanna Zaleska; Ireneusz W Krasnodebski Journal: J Clin Immunol Date: 2002-09 Impact factor: 8.317
Authors: Travis L Holloway; Susannah E Nicholson; Meenakshi Rani; Andrew P Cap; Martin G Schwacha Journal: J Surg Res Date: 2016-06-25 Impact factor: 2.192
Authors: J Jason Hoth; Jonathan D Wells; Noel A Brownlee; Elizabeth M Hiltbold; J Wayne Meredith; Charles E McCall; Barbara K Yoza Journal: Shock Date: 2009-04 Impact factor: 3.454
Authors: Carl I Schulman; Jaime Uribarri; Weijing Cai; Ron Manning; David C Landy; Margaret Gallardo; Angela Castillo; Nicholas Namias; Gary E Striker; Alan Livingstone; Helen Vlassara Journal: Clin Chem Lab Med Date: 2014-01-01 Impact factor: 3.694
Authors: Ana Moran; Stephen A Thacker; Ayse Akcan Arikan; Mary-Ann A Mastrangelo; Yong Wu; Bi Yu; David J Tweardy Journal: PLoS One Date: 2011-06-29 Impact factor: 3.240
Authors: Jan O Jansen; Janet M Lord; David R Thickett; Mark J Midwinter; Daniel F McAuley; Fang Gao Journal: Crit Care Date: 2013-05-29 Impact factor: 9.097
Authors: Carlos F M Morris; Muhammad Tahir; Samina Arshid; Mariana S Castro; Wagner Fontes Journal: J Immunol Res Date: 2015-12-06 Impact factor: 4.818